Pediatric diabetes

Julian Hamilton-Shield explains why weight loss is the key to type 2 diabetes management in children (2:04).

We round up the medications currently approved for treating type 2 diabetes in children and adolescents and look at what agents are coming through clinical trials.

Why and how does ethnicity influence risk and management approach for pediatric type 2 diabetes? We talk to childhood obesity specialist Julian Hamilton-Shield.

Torsten Olbers puts the case for metabolic surgery as a treatment option for children with type 2 diabetes.

Phil Zeitler discusses the pathophysiology of type 2 diabetes in children, and why it is so resistant to conventional management (2:58). 

AG Unnikrishnan highlights the problem of underdiagnosis of type 2 diabetes in children, and explains who to prioritize for screening (2:14).

Read our quick round-up of the AWARD trials of the GLP-1 receptor agonist dulaglutide in people with type 2 diabetes.

Medical sociologist Ashby Walker talks about a mentoring scheme pairing college students and teenagers who have type 1 diabetes - to the benefit of both (9:14).

Our clinical advisors discuss their EASD 2019 highlights, including new treatment options for children and older adults with type 2 diabetes, the complexities surrounding hypoglycemia prevention, and the implications of the VERIFY trial.

What does the proliferation of diabetes self-management and monitoring technologies in pediatric care mean for the future of adult services? Katharine Barnard looks at the situation in England and Wales.

These slides detail a study of flash glucose monitoring in children and adolescents, showing good accuracy relative to capillary blood glucose testing during up to 14 days of use, along with high acceptability of the device. 
Source: Edge J, Acerini C, Campbell F, et al. Arch Dis Child 2017; 102: 543–549
Funded by an educational grant from Abbott Diabetes Care

The effect of sleep duration on glucose regulation and cardiometabolic risk is becoming an increasingly high-profile issue. medwireNews takes a look at the latest evidence, which shows the gravity of the problem but also offers some solutions.

As the utility and availability of devices surges, so too do patient expectations. Advisory Board member Katharine Barnard provides key consultation questions to help determine your patients’ greatest needs and obstacles.

Professor Moshe Phillip tells medwireNews why he believes the artificial pancreas will be of particular benefit for adolescents and young adults with type 1 diabetes.